Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
WHTCF
WELL Health Technologies Corp.
|
$261.9M | -- | 101.94% | -- | -- |
|
AIRS
AirSculpt Technologies, Inc.
|
$39.8M | -$0.02 | -10.84% | -65.36% | $6.00 |
|
CVS
CVS Health Corp.
|
$98.8B | $1.36 | 6.44% | -24.01% | $94.33 |
|
IQV
IQVIA Holdings, Inc.
|
$4.1B | $2.98 | 7.15% | 40.55% | $253.95 |
|
UNVC
UNIVEC
|
-- | -- | -- | -- | -- |
|
WORX
SCWorx Corp.
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
WHTCF
WELL Health Technologies Corp.
|
$2.84 | -- | $721.5M | 40.43x | $0.00 | 0% | 0.83x |
|
AIRS
AirSculpt Technologies, Inc.
|
$2.12 | $6.00 | $132.4M | 300.71x | $0.00 | 0% | 0.80x |
|
CVS
CVS Health Corp.
|
$78.04 | $94.33 | $99.1B | 203.97x | $0.67 | 3.41% | 0.25x |
|
IQV
IQVIA Holdings, Inc.
|
$225.15 | $253.95 | $38.3B | 30.91x | $0.00 | 0% | 2.49x |
|
UNVC
UNIVEC
|
$0.0025 | -- | $453K | -- | $0.00 | 0% | -- |
|
WORX
SCWorx Corp.
|
$0.20 | -- | $3.2M | -- | $0.00 | 0% | 0.30x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
WHTCF
WELL Health Technologies Corp.
|
42.5% | 1.511 | 43.07% | 0.83x |
|
AIRS
AirSculpt Technologies, Inc.
|
51.18% | 9.660 | 17.19% | 0.22x |
|
CVS
CVS Health Corp.
|
52.85% | 0.779 | 85.22% | 0.49x |
|
IQV
IQVIA Holdings, Inc.
|
71.15% | 1.008 | 46.77% | 0.62x |
|
UNVC
UNIVEC
|
-- | 1.393 | -- | -- |
|
WORX
SCWorx Corp.
|
0.05% | 2.173 | 0.08% | 1.15x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
WHTCF
WELL Health Technologies Corp.
|
$101.1M | $24.2M | -3.93% | -6.12% | 9.13% | $14.1M |
|
AIRS
AirSculpt Technologies, Inc.
|
$16.9M | -$1.3M | -10.01% | -21.8% | -3.72% | -$405K |
|
CVS
CVS Health Corp.
|
$13.8B | $3B | 0.27% | 0.57% | 2.88% | $98M |
|
IQV
IQVIA Holdings, Inc.
|
$1.1B | $572M | 6.13% | 20.65% | 13.96% | $772M |
|
UNVC
UNIVEC
|
-- | -- | -- | -- | -- | -- |
|
WORX
SCWorx Corp.
|
$119.1K | -$138.9K | -74.13% | -74.77% | -19.68% | -$358.1K |
AirSculpt Technologies, Inc. has a net margin of -0.73% compared to WELL Health Technologies Corp.'s net margin of -27.18%. WELL Health Technologies Corp.'s return on equity of -6.12% beat AirSculpt Technologies, Inc.'s return on equity of -21.8%.
| Company | Gross Margin | Earnings Per Share | Invested Capital |
|---|---|---|---|
|
WHTCF
WELL Health Technologies Corp.
|
38.19% | $0.01 | $1.2B |
|
AIRS
AirSculpt Technologies, Inc.
|
48.33% | -$0.15 | $168.2M |
WELL Health Technologies Corp. has a consensus price target of --, signalling downside risk potential of --. On the other hand AirSculpt Technologies, Inc. has an analysts' consensus of $6.00 which suggests that it could grow by 179.07%. Given that AirSculpt Technologies, Inc. has higher upside potential than WELL Health Technologies Corp., analysts believe AirSculpt Technologies, Inc. is more attractive than WELL Health Technologies Corp..
| Company | Buy Ratings | Hold Ratings | Sell Ratings |
|---|---|---|---|
|
WHTCF
WELL Health Technologies Corp.
|
0 | 0 | 0 |
|
AIRS
AirSculpt Technologies, Inc.
|
0 | 3 | 0 |
WELL Health Technologies Corp. has a beta of 1.383, which suggesting that the stock is 38.311% more volatile than S&P 500. In comparison AirSculpt Technologies, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
WELL Health Technologies Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. AirSculpt Technologies, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. WELL Health Technologies Corp. pays -- of its earnings as a dividend. AirSculpt Technologies, Inc. pays out 3.05% of its earnings as a dividend. AirSculpt Technologies, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
WELL Health Technologies Corp. quarterly revenues are $264.7M, which are larger than AirSculpt Technologies, Inc. quarterly revenues of $35M. WELL Health Technologies Corp.'s net income of -$1.9M is higher than AirSculpt Technologies, Inc.'s net income of -$9.5M. Notably, WELL Health Technologies Corp.'s price-to-earnings ratio is 40.43x while AirSculpt Technologies, Inc.'s PE ratio is 300.71x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for WELL Health Technologies Corp. is 0.83x versus 0.80x for AirSculpt Technologies, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
| Company | Price/Sales Ratio | Price/Earnings Ratio | Quarterly Revenue | Quarterly Net Income |
|---|---|---|---|---|
|
WHTCF
WELL Health Technologies Corp.
|
0.83x | 40.43x | $264.7M | -$1.9M |
|
AIRS
AirSculpt Technologies, Inc.
|
0.80x | 300.71x | $35M | -$9.5M |
CVS Health Corp. has a net margin of -0.73% compared to WELL Health Technologies Corp.'s net margin of -3.88%. WELL Health Technologies Corp.'s return on equity of -6.12% beat CVS Health Corp.'s return on equity of 0.57%.
| Company | Gross Margin | Earnings Per Share | Invested Capital |
|---|---|---|---|
|
WHTCF
WELL Health Technologies Corp.
|
38.19% | $0.01 | $1.2B |
|
CVS
CVS Health Corp.
|
13.43% | -$3.13 | $154.9B |
WELL Health Technologies Corp. has a consensus price target of --, signalling downside risk potential of --. On the other hand CVS Health Corp. has an analysts' consensus of $94.33 which suggests that it could grow by 20.88%. Given that CVS Health Corp. has higher upside potential than WELL Health Technologies Corp., analysts believe CVS Health Corp. is more attractive than WELL Health Technologies Corp..
| Company | Buy Ratings | Hold Ratings | Sell Ratings |
|---|---|---|---|
|
WHTCF
WELL Health Technologies Corp.
|
0 | 0 | 0 |
|
CVS
CVS Health Corp.
|
17 | 4 | 0 |
WELL Health Technologies Corp. has a beta of 1.383, which suggesting that the stock is 38.311% more volatile than S&P 500. In comparison CVS Health Corp. has a beta of 0.481, suggesting its less volatile than the S&P 500 by 51.936%.
WELL Health Technologies Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. CVS Health Corp. offers a yield of 3.41% to investors and pays a quarterly dividend of $0.67 per share. WELL Health Technologies Corp. pays -- of its earnings as a dividend. CVS Health Corp. pays out 72.76% of its earnings as a dividend. CVS Health Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
WELL Health Technologies Corp. quarterly revenues are $264.7M, which are smaller than CVS Health Corp. quarterly revenues of $102.9B. WELL Health Technologies Corp.'s net income of -$1.9M is higher than CVS Health Corp.'s net income of -$4B. Notably, WELL Health Technologies Corp.'s price-to-earnings ratio is 40.43x while CVS Health Corp.'s PE ratio is 203.97x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for WELL Health Technologies Corp. is 0.83x versus 0.25x for CVS Health Corp.. Usually stocks with elevated PS ratios are considered overvalued.
| Company | Price/Sales Ratio | Price/Earnings Ratio | Quarterly Revenue | Quarterly Net Income |
|---|---|---|---|---|
|
WHTCF
WELL Health Technologies Corp.
|
0.83x | 40.43x | $264.7M | -$1.9M |
|
CVS
CVS Health Corp.
|
0.25x | 203.97x | $102.9B | -$4B |
IQVIA Holdings, Inc. has a net margin of -0.73% compared to WELL Health Technologies Corp.'s net margin of 8.1%. WELL Health Technologies Corp.'s return on equity of -6.12% beat IQVIA Holdings, Inc.'s return on equity of 20.65%.
| Company | Gross Margin | Earnings Per Share | Invested Capital |
|---|---|---|---|
|
WHTCF
WELL Health Technologies Corp.
|
38.19% | $0.01 | $1.2B |
|
IQV
IQVIA Holdings, Inc.
|
26.49% | $1.93 | $21.5B |
WELL Health Technologies Corp. has a consensus price target of --, signalling downside risk potential of --. On the other hand IQVIA Holdings, Inc. has an analysts' consensus of $253.95 which suggests that it could grow by 12.79%. Given that IQVIA Holdings, Inc. has higher upside potential than WELL Health Technologies Corp., analysts believe IQVIA Holdings, Inc. is more attractive than WELL Health Technologies Corp..
| Company | Buy Ratings | Hold Ratings | Sell Ratings |
|---|---|---|---|
|
WHTCF
WELL Health Technologies Corp.
|
0 | 0 | 0 |
|
IQV
IQVIA Holdings, Inc.
|
16 | 5 | 0 |
WELL Health Technologies Corp. has a beta of 1.383, which suggesting that the stock is 38.311% more volatile than S&P 500. In comparison IQVIA Holdings, Inc. has a beta of 1.366, suggesting its more volatile than the S&P 500 by 36.638%.
WELL Health Technologies Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. IQVIA Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. WELL Health Technologies Corp. pays -- of its earnings as a dividend. IQVIA Holdings, Inc. pays out -- of its earnings as a dividend.
WELL Health Technologies Corp. quarterly revenues are $264.7M, which are smaller than IQVIA Holdings, Inc. quarterly revenues of $4.1B. WELL Health Technologies Corp.'s net income of -$1.9M is lower than IQVIA Holdings, Inc.'s net income of $332M. Notably, WELL Health Technologies Corp.'s price-to-earnings ratio is 40.43x while IQVIA Holdings, Inc.'s PE ratio is 30.91x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for WELL Health Technologies Corp. is 0.83x versus 2.49x for IQVIA Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
| Company | Price/Sales Ratio | Price/Earnings Ratio | Quarterly Revenue | Quarterly Net Income |
|---|---|---|---|---|
|
WHTCF
WELL Health Technologies Corp.
|
0.83x | 40.43x | $264.7M | -$1.9M |
|
IQV
IQVIA Holdings, Inc.
|
2.49x | 30.91x | $4.1B | $332M |
UNIVEC has a net margin of -0.73% compared to WELL Health Technologies Corp.'s net margin of --. WELL Health Technologies Corp.'s return on equity of -6.12% beat UNIVEC's return on equity of --.
| Company | Gross Margin | Earnings Per Share | Invested Capital |
|---|---|---|---|
|
WHTCF
WELL Health Technologies Corp.
|
38.19% | $0.01 | $1.2B |
|
UNVC
UNIVEC
|
-- | -- | -- |
WELL Health Technologies Corp. has a consensus price target of --, signalling downside risk potential of --. On the other hand UNIVEC has an analysts' consensus of -- which suggests that it could fall by --. Given that WELL Health Technologies Corp. has higher upside potential than UNIVEC, analysts believe WELL Health Technologies Corp. is more attractive than UNIVEC.
| Company | Buy Ratings | Hold Ratings | Sell Ratings |
|---|---|---|---|
|
WHTCF
WELL Health Technologies Corp.
|
0 | 0 | 0 |
|
UNVC
UNIVEC
|
0 | 0 | 0 |
WELL Health Technologies Corp. has a beta of 1.383, which suggesting that the stock is 38.311% more volatile than S&P 500. In comparison UNIVEC has a beta of -0.101, suggesting its less volatile than the S&P 500 by 110.112%.
WELL Health Technologies Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. UNIVEC offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. WELL Health Technologies Corp. pays -- of its earnings as a dividend. UNIVEC pays out -- of its earnings as a dividend.
WELL Health Technologies Corp. quarterly revenues are $264.7M, which are larger than UNIVEC quarterly revenues of --. WELL Health Technologies Corp.'s net income of -$1.9M is higher than UNIVEC's net income of --. Notably, WELL Health Technologies Corp.'s price-to-earnings ratio is 40.43x while UNIVEC's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for WELL Health Technologies Corp. is 0.83x versus -- for UNIVEC. Usually stocks with elevated PS ratios are considered overvalued.
| Company | Price/Sales Ratio | Price/Earnings Ratio | Quarterly Revenue | Quarterly Net Income |
|---|---|---|---|---|
|
WHTCF
WELL Health Technologies Corp.
|
0.83x | 40.43x | $264.7M | -$1.9M |
|
UNVC
UNIVEC
|
-- | -- | -- | -- |
SCWorx Corp. has a net margin of -0.73% compared to WELL Health Technologies Corp.'s net margin of -185.96%. WELL Health Technologies Corp.'s return on equity of -6.12% beat SCWorx Corp.'s return on equity of -74.77%.
| Company | Gross Margin | Earnings Per Share | Invested Capital |
|---|---|---|---|
|
WHTCF
WELL Health Technologies Corp.
|
38.19% | $0.01 | $1.2B |
|
WORX
SCWorx Corp.
|
16.88% | -$0.15 | $6M |
WELL Health Technologies Corp. has a consensus price target of --, signalling downside risk potential of --. On the other hand SCWorx Corp. has an analysts' consensus of -- which suggests that it could fall by --. Given that WELL Health Technologies Corp. has higher upside potential than SCWorx Corp., analysts believe WELL Health Technologies Corp. is more attractive than SCWorx Corp..
| Company | Buy Ratings | Hold Ratings | Sell Ratings |
|---|---|---|---|
|
WHTCF
WELL Health Technologies Corp.
|
0 | 0 | 0 |
|
WORX
SCWorx Corp.
|
0 | 0 | 0 |
WELL Health Technologies Corp. has a beta of 1.383, which suggesting that the stock is 38.311% more volatile than S&P 500. In comparison SCWorx Corp. has a beta of 1.922, suggesting its more volatile than the S&P 500 by 92.248%.
WELL Health Technologies Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. SCWorx Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. WELL Health Technologies Corp. pays -- of its earnings as a dividend. SCWorx Corp. pays out -- of its earnings as a dividend.
WELL Health Technologies Corp. quarterly revenues are $264.7M, which are larger than SCWorx Corp. quarterly revenues of $705.8K. WELL Health Technologies Corp.'s net income of -$1.9M is lower than SCWorx Corp.'s net income of -$1.3M. Notably, WELL Health Technologies Corp.'s price-to-earnings ratio is 40.43x while SCWorx Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for WELL Health Technologies Corp. is 0.83x versus 0.30x for SCWorx Corp.. Usually stocks with elevated PS ratios are considered overvalued.
| Company | Price/Sales Ratio | Price/Earnings Ratio | Quarterly Revenue | Quarterly Net Income |
|---|---|---|---|---|
|
WHTCF
WELL Health Technologies Corp.
|
0.83x | 40.43x | $264.7M | -$1.9M |
|
WORX
SCWorx Corp.
|
0.30x | -- | $705.8K | -$1.3M |
Signup to receive the latest stock alerts
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 36x
Market Cap: $3.8T
P/E Ratio: 39x
Applied Optoelectronics, Inc. [AAOI] is up 3.95% over the past day.
Zenas BioPharma, Inc. [ZBIO] is up 1.18% over the past day.
UniFirst Corp. [UNF] is up 0.77% over the past day.